

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and⦠read more
Healthcare
Medical Devices
12 years
USD
Exclusive to Premium users
$1.68
Price+1.82%
$0.03
$98.090m
Small
-
Premium
Premium
-2756.1%
EBITDA Margin-2756.1%
Net Profit Margin-133.4%
Free Cash Flow Margin-2756.1%
EBITDA Margin-2756.1%
Net Profit Margin-133.4%
Free Cash Flow Margin$9.589m
+59.4%
1y CAGR+365.8%
3y CAGR+269.8%
5y CAGR-$136.849m
-234.7%
1y CAGR-171.9%
3y CAGR-119.6%
5y CAGR-$33.93
-1734.0%
1y CAGR-545.4%
3y CAGR-391.0%
5y CAGR$197.897m
$200.708m
Assets$2.811m
Liabilities-
Debt0.0%
-
Debt to EBITDA-$17.809m
+70.9%
1y CAGR-129.9%
3y CAGR-90.6%
5y CAGR